CJ
AQST icon

Caitlin John’s Aquestive Therapeutics AQST Stock Holding History

Caitlin John’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.57K Hold
2,300
– – 0.01% 600
2026
Q1 		$9.54K Sell
2,300
-500
-18% -$2.03K 0.01% 530
2025
Q4 		$18.1K Sell
2,800
-100
-3% -$623 0.01% 454
2025
Q3 		$16.2K Buy
+2,900
New +$12.5K 0.01% 430
2025
Q1 		– Sell
-5,900
Closed -$21K – 168
2024
Q4 		$21K Sell
5,900
-500
-8% -$2.31K 0.01% 370
2024
Q3 		$30.9K Buy
6,400
+2,200
+52% +$8.56K 0.02% 311
2024
Q2 		$10.9K Buy
+4,200
New +$14K 0.01% 447

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Caitlin John's AQST Position: Q2 2026 in Review

Caitlin John held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 2,300 shares worth $9.57K. The position accounts for 0.01% of the portfolio, ranked #600.

Caitlin John first reported a position in AQST in Q2 2024 and has held it in 7 quarters since. The position peaked at $30.9K in Q3 2024. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Caitlin John held 2,300 shares of Aquestive Therapeutics worth $9.57K as of Q2 2026.
  • Caitlin John left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up 0.01% of Caitlin John's portfolio in Q2 2026, its #600 holding.
  • Caitlin John first reported a position in Aquestive Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Caitlin John's Aquestive Therapeutics position peaked at $30.9K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.